Vascular cognitive impairment in India: Challenges and opportunities for prevention and treatment

Faheem Arshad1, Samim Mm1, Avanthi Paplikar1

  • 1Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India.

Insights

Vascular dementia poses a significant health challenge in India, affecting millions. Addressing this requires tailored strategies considering diverse risk factors and improving research infrastructure for better prevention and treatment.

Area of Science:

  • Neurology
  • Public Health
  • Epidemiology

Background:

  • Vascular contribution to cognitive impairment and dementia is a major health concern in India.
  • Approximately 5.3 million people in India have dementia, with vascular dementia accounting for about 40%.

Purpose of the Study:

  • To highlight the unique challenges in reducing the burden of vascular dementia and vascular cognitive impairment (VCI) in India.
  • To underscore the need for context-specific research and intervention strategies for VCI in India.

Main Methods:

  • Analysis of existing data on dementia prevalence and risk factors in India.
  • Identification of challenges including heterogeneity in risk profiles, socioeconomic factors, and limited research infrastructure.
  • Review of ongoing efforts in population-level cardiovascular risk reduction and VCI diagnosis.

Main Results:

  • Significant challenges exist in implementing uniform preventive and therapeutic strategies for VCI due to diverse factors.
  • Limited longitudinal data on vascular disease natural history and lack of advanced neuroimaging/genetic information hinder understanding of VCI pathophysiology.
  • Development of culturally appropriate cognitive measures and establishment of multicentric stroke cohorts are underway.

Conclusions:

  • Addressing the growing burden of VCI in India necessitates filling critical research gaps.
  • Developing tailored intervention strategies for the Indian population is crucial for effective VCI management and prevention.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
246
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.4K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
626